Colossal Biosciences
Austin · Founded 2021
About Colossal Biosciences
Colossal Biosciences is a bioscience and genetic engineering company focused on restoring extinct species and protecting endangered ones. Utilizing advanced gene editing technologies like CRISPR, the company aims to revive species such as the woolly mammoth and enhance ecosystems. Through innovative approaches, Colossal seeks to address the urgent challenges of extinction and biodiversity loss.
Company Facts
- Founded: 2021
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 101 – 250
- Estimated revenue: $10K – $50K
- Total funding: $628.1M
- Funding stage: Late Stage Venture
- Last round: Series C (Feb 2026)
- Website: colossal.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Genetics, Life Science
Social Profiles
Canonical: https://fsome.com/organization/colossal-biosciences-64913 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.